Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy:

Christie M. Ballantyne,Ulrich Laufs,Kausik K. Ray,Lawrence A. Leiter,Harold E. Bays,Anne C. Goldberg,Erik S.G. Stroes,Diane MacDougall,Xin Zhao,Alberico L. Catapano

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy:

2019

Christie M. Ballantyne
Ulrich Laufs
Kausik K. Ray
Lawrence A. Leiter
Harold E. Bays
Anne C. Goldberg
Erik S.G. Stroes
Diane MacDougall
Xin Zhao
Alberico L. Catapano

AimsThe aim of this study was to evaluate the low-density lipoprotein cholesterol lowering efficacy and safety of a bempedoic acid 180 mg and ezetimibe 10 mg fixed-dose combination in patients with...

Keywords:

Hyperlipidemia
Physical therapy
Pharmacology
Diabetes mellitus
Fixed-dose combination
Cholesterol
Hypolipidemic Agents
Lipoprotein
Medicine
Ezetimibe
Statin
Apolipoprotein B
Urology
in patient
Bempedoic acid
C-reactive protein

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations